TWST Twist Bioscience Corporation
TWST Twist Bioscience Corporation
Healthcare · Diagnostics & Research
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $27.39 · VWAP $83.18 · +59.6% vs 12m avg buyer
Insiders selling 0 buy / 2 sell · Form 4, 90d $70.5M sold last open-market sell Leproust Emily M.
Cluster CEO, CFO + 5 others sold $22.5M, Aug 14–27
Coverage
1 related campaign
TWST Price Structure
Loading timeframes…
Peers
Every watchlist TWST belongs to, members best 30-day change first — TWST highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
@ibb
Decision history
1 scored call · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported the quarter ending 2026-06-30: revenue $118M, diluted EPS -$0.56, net income -$35M (SEC filing). Across the print the stock moved +8.6% (close before → first close after).
full note →Against street estimates
How TWST's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about TWST from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 11 days ago · Oct 6
- Twist Bioscience (NASDAQ:TWST) CEO Sells 655 Shares of Company Stock
- Twist Bioscience stock gained 8.66 percent after Lilly deal on October 5, 2026
- Twist Bioscience (TWST) Stock Price & Overview
- Twist Bioscience | Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results
- Twist Bioscience | Press Releases
TWST research tape
74 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to TWST.
Vertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries